Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label study of cetuximab with cisplatin and docetaxel in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma
2006-002512-10Phase 2Completed
- Sponsor
- An-Institut für Qualitätssicherung in der operativen Medizin
- Start
- Jun 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab, cisplatin and docetaxel in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma, sponsored by An-Institut für Qualitätssicherung in der operativen Medizin. Primary endpoint: Study end definition. Started Jun 2006; status: completed.
02
Drugs
cetuximabcisplatindocetaxel
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on 2006-002512-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002512-10.